X0306 4 2018-09-24 1 0001390478 SELLAS Life Sciences Group, Inc. SLS 0001724449 Lopez Fabio EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON D0 HM08 BERMUDA 0 0 0 1 Former Director, 10% holder 0001724585 EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724529 EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724530 EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund` C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724701 Equilibria Capital Management Ltd C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724523 Castilian Ltd. C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724811 Varibobi Financial Holdings Ltd C/O EQUILIABRIA CAPITAL MANAGEMENT LTD. O'HARA HOUSE, ONE BERMUDIANA ROAD HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724558 Tafur Daniel C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON D0 HM08 BERMUDA 0 0 1 0 0001724539 EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund C/O EQUILIBRIA CAPITAL MANAGEMENT LTD. ONE BERMUDIANA ROAD HAMILTON HM08 0 0 1 0 Common Stock 2018-09-24 4 J 0 1521863 0.00 D 0 D Common Stock 2018-09-24 4 J 0 676324 0.00 D 0 D Common Stock 2018-09-24 4 J 0 325799 0.00 D 0 D EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund ("Sely S") distributed 1,521,863 shares to its partners on a pro rata basis, for no consideration. As a partner of Sely S, Fabio Lopez, received 19,524 of the shares distributed by Sely S. EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund ("Sely I") distributed 676,324 shares to its partners on a pro rata basis, for no consideration. As partners of Sely I, Daniel Tafur and Equilibria Capital Management received 13,871 and 107,619, respectively, of the shares distributed by Sely I. EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund ("Sely II") distributed 325,799 shares to its partners on a pro rata basis, for no consideration. As partners of Sely II, Fabio Lopez and Daniel Tafur received 6,325 and 2,372, respectively, of the shares distributed by Sely II. Fabio Lopez, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 EQC Private Markets SAC Fund II Ltd EQC Biotech Sely S Fund, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 EQC Private Markets SAC Fund Ltd EQC Biotech Sely I Fund, Daniel Tafur, Director, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 EQC Private Markets SAC Fund Ltd EQC Biotech Sely II Fund, Daniel Tafur, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 EQC Private Markets II SAC Fund Ltd EQC Biotech Sely III Fund, Daniel Tafur, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 Equilibria Capital Management Limited, Daniel Tafur, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 Castilian, Ltd., Daniel Tafur, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 Varibobi Financial Holdings Ltd., Fabio Lopez, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25 Daniel Tafur, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-09-25